Design. Formulate. Deliver. ten23 health is the human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow’s medicines. Our sites in Visp and Basel 🇨🇭 support our clients in developing differentiated, stable, usable, and safe injectable treatments for patients. More about us: www.ten23.health biopharmaceuticals, pharmaceutical industry, Contract Manufacturing, Sterile Manufacturing, Aseptic Manufacturing, Drug Device Integration, Analytical Development, Analytical Testing, Molecule Selection, Packaging , and Formulation Development

227 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Innovating and sharing ideas since 1992 INMUNOTEK is a pharmaceutical company dedicated to researching, developing, manufacturing, and distributing therapeutic vaccines for allergies, infectious diseases, and cancer. The company also produces and markets medical devices. Founded in 1992, INMUNOTEK's mission is to improve patients' quality of life and provide value to healthcare professionals by offering innovative, safe, and effective products. Our products are available in Spain and over 50 other countries worldwide through subsidiaries, sales offices, and exclusive distributors. We operate two production centers located in San Sebastián de los Reyes and Alcalá de Henares, Madrid, Spain, both of which are …

49 similar entities Type: SMB Activities: manufacturing deeptech biotech healthtech Technologies: Synthetic Biology

Our mission: patient: help inside. We use biotechnology to treat serious illnesses. Amgen was founded in 1980 and is now a globally leading independent biotechnology company, which is represented in almost 100 countries with around 28,000 employees. As a pioneer of biotechnology, we have four decades of experience in research, development and production of innovative human therapy. We focus on illnesses for which there are only a few or no therapy options. Every year, millions of patients with serious illnesses benefit from our therapies worldwide. Our medicines are used in nephrology, cardiology, hematology, oncology, bone health, in chronic inflammatory and …

12 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Partner of choice in specialty, hospital, and rare disease medicines Partner of choice in specialty, hospital, and rare disease medicines ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the specialty, hospital, and rare disease medicines they depend on. Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are partnering with innovative biopharma and pharmaceutical development companies to bring medicines to patients. Headquartered in London, UK, we have commercial sales in more …

62 similar entities Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Innovating to Enhance Quality of Life Fitabeo Therapeutics is a clinical-stage specialty pharmaceutical company that develops and commercialises a differentiated portfolio of innovative medicines focusing on indications where existing treatments are inadequate for the target population. It deploys breakthrough technologies to develop medicines that enable patient autonomy, decentralise patient care and provide superior health outcomes. Oral Thin Films, Geriatrics, Paediatrics, Patient autonomy, Equitable Access, Innovative medicines, Medication adherence, Central Nervous System, Women's Health, and Neurology

315 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Wellness made simple. Thoughtful formulations designed to support everyday vitality and long-term health. Our thoughtfully formulated supplements are designed to support your energy, resilience, and long-term health without the noise or complexity. Whether foundational or targeted, every product is backed by science and crafted to meet you where you are - because real wellness should feel natural, not overwhelming. We’re here to make daily health a little easier, and a lot more empowering. Histamine, Heavy metals, Vitamin D testing and supplements, Food intolerance, Helicobacter pylori, Allergies, Histamine intolerance, Customer service, Nutrition advice, Migraines, Headaches, Electrolytes, Daily health, and Wellness

60 similar entities Type: Startup Activities: healthtech Technologies: Bio sourced materials

We are a biopharmaceutical company dedicated?to transforming the future for underserved, global patient populations in bone health and related areas. We consistently embrace opportunities to improve the lives of our patients, their caregivers, our communities, our partners, and each other.

323 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

We have always invented for one and great purpose: life We have always invented for a single great purpose: life MSD, known in the United States and Canada with the name of Merck & Amp; Co., Inc., with headquarters in Kenilworth, (New Jersey, USA), is an American multinational leader in the pharmaceutical sector. For over 65 years in Italy and 130 in the world, we have revolutionized the therapeutic paradigms for dozens of pathologies through the discovery of over 200 innovative molecules. Our mission is to discover, develop, make innovative products and services available that save and improve the lives …

36 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

#BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine New ideas, new innovations, new ways of thinking for the medical device industry. We are a pharmaceutical company specialized in the discovery, clinical development, production and commercialization of innovative products in the field of regenerative medicine. At Bioxis Pharmaceuticals, we contribute to transform science into groundbreaking medical device that meet doctors need to improve the health and well-being of their patients in the field of dermatology and aesthetic medicine. Medical Device, Dermatology, Aesthetic, Cosmetic surgery, Regenerative medicine, Ultra-pure chitosan, and Hyaluronic Acid

301 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology

Cabinet de conseil en stratégie spécialisé dans les problématiques de santé Nextep, a catalyst for ideas and expertise : "When all healthcare players want to create more value for patients " Founded in 1999, Nextep is an independent healthcare consultancy firm specialized in 6 complementary practices: Strategy & Performance; Business Development; Public Affairs & Strategic communication; Market Access & Health Economics; Training; Publishing Specialized in strategic health issues. Our interventions for customers throughout Europe and the United States are intended to support managers – from innovative SMEs to multinationals – in their development, both in medicine, biotech, the “medical device” …

205 similar entities Type: SMB Activities: consulting govtech healthtech Technologies: Synthetic Biology

Kyowa Kirin North America is a specialty pharmaceutical company dedicated to making a profound impact on patient lives. Kyowa Kirin is a global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines. We work on some of the hardest to treat diseases where need is high, and potential for life-changing impact is possible. The North America organization includes offices in Princeton, NJ; Toronto, Canada and a research facility in La Jolla, CA. Together, we work as a collaborative team to understand clinical needs and advance innovations that have a profound impact on patient lives. Our growth …

59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Developing novel IVD solutions Genz is a spin-off biotech company developing novel solutions from in vitro diagnostics to therapeutics. Our mission is to deliver a consistent stream of innovative, affordable, and accessible diagnostic solutions and make a remarkable impact on people’s lives. We’re focused on sustainable growth and addressing the world’s pressing health challenges; therefore, we’re able to create value for both our patients and our shareholders. To date, Genz developed 4 IVD diagnostic tests commercially legalized, attended International joint projects, partnered with top research centers in the world and published several scientific articles in international scientific journals. Biotechnology, Genetik …

161 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Better Access. Better Lives. Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars. Biopharmaceuticals, Research and Development, Biosimilars, Biotechnology, Pharmaceutical, Biogenerics, Health, Cell Line Development, Business Development, and Regulatory

232 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Empowering the Swiss Heath Valley Empowering the Swiss Health Valley. Life Sciences Cluster, Medtech, Biotech, Pharma, Digital Health, Foodtech, Cosmetics Networking, Life Sciences, Biotech, Medtech, Nutrition, Cosmetic, Diagnostic, Neurosciences, Medical, Technology, Switzerland, Biotech, Pharma, HealthValley, Innovation, Healthtech, femtech, Switzerland, and Foodtech

59 similar entities Type: SMB Activities: healthtech deeptech

Better Medicine For All Better Medicine for All MedinCell is a pharmaceutical company at commercial stage. We develop a portfolio of long-acting injectables in various therapeutic areas. Our proprietary technology BEPO® aims to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. We collaborate with tier-one pharmaceutical companies and foundations to improve Global Health through new therapeutic options. Our mission is to contribute to the improvement and protection of the health of populations across the world. The fair sharing of the value created with all our employees is the foundation of our business model. …

73 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Focusing on innovation for health solutions since 1990, Stragen is a global player in the development, registration and distribution of Generic drugs and Consumer Health products. Starting as a small API trading platform 30 years ago in Geneva, Switzerland, today Stragen operates in over 60 markets through a network of dynamic and collaborative partners, employing over 150 people and working with 10 dedicated affiliates worldwide. As a result of decades of experience and expertise in R&D, combined with our continuous commitment to advancing public health, we invest in the fundamental research through to the delivery of innovative and trusted health …

52 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Making the hope of early detection, a reality. Meet the team behind iBreastExam and cervAIcal! UE LifeSciences is a fast-growing, multi-national med-tech company bringing the promise of early detection of cancer to women globally. Our innovations have reached more than 250,000 women in 12 countries. We've grown revenue five-fold in the past three years with distribution in 10 countries and counting. And we've raised over $6 million in grants, international awards and equity capital! Our work is featured on platforms such as TED Talks and notable publications such as The New York Times, BBC World News, Forbes and others. Medical …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology. The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions. We focus on disease areas where the magnitude of R&D investment from industry is disproportionately low relative to societal medical needs. In addition to our biopharmaceutical …

66 similar entities Type: Startup Activities: biotech deeptech

Intuitive Innovation for Infection Prevention We believe that innovation is the key to success in Medical Device Market. Innovation, creation & patient well-being are in our DNA, we dare to go further, whether single-handedly or in partnership with our customers, while thinking outside the box thanks to our specialization and expertise in the medical industry. We can offer you our know-how, specific skills and expertise in technical consultancy for your projects in clean room injection, surface treatment and sterile packaging of your medical devices, through our different divisions SELENIUM Injection, SELENIUM Surface Treatment and SELENIUM Packaging. In all our divisions, …

96 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Your innovation experts in natural health products Since a&r was founded, our purpose has been to act as your innovation expert in natural health products. Within the consumer health care space, a&r is one of the leading consultancies and clinical research organizations with a strong focus on natural health products. For more than two decades we have been supporting our clients with scientific, regulatory, and clinical expertise. With experience, enthusiasm and strong result orientation we apply our core competences: the compilation of dossiers for market compliance in Europe and the performance of clinical studies according to local and international requirements. …

63 similar entities Type: SMB Activities: deeptech healthtech Technologies: Bio sourced materials

Blood Pressure Intelligence for Global Health Aktiia, now trading under Hilo, was established in 2018 to transform how blood pressure is measured and therefore managed. Hilo is transforming blood pressure monitoring with cuffless, AI-powered technology that delivers continuous, accessible insights for individuals and healthcare professionals. Our foundation model is trained on billions of optical signals and hundreds of millions of readings from over 120,000 users—one of the largest datasets in the field. Backed by a multidisciplinary team with deep expertise in biomedical signal processing, Hilo has contributed to over 120 peer-reviewed publications and holds more than 35 patents. Headquartered in …

36 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

The leading marketplace for cutting-edge medical innovations in maternal, newborn & reproductive health. Maternova, Inc. is the leading trusted resource for cutting edge medical innovations in women's health and newborn health. Governments, Ministries of Health, NGO's and healthcare professionals around the world partner with Maternova to procure trusted and rigorously tested pathbreaking technologies. We have a network of over 50,000 policymakers, clinicians, midwives, and thought leaders as part of our sphere of influence. To learn more about how your organization can work with Maternova, as either a client or manufacturer looking to commercialize your products, please contact us. Learn more: …

Type: Startup Activities: healthtech biotech civictech deeptech Technologies: Synthetic Biology

MD Start is a fund, a team of entrepreneurs and an incubator combined, aimed at transforming innovative ideas into medical realities. Our mission is to incubate medical device innovations to the point where proof-of-principle in patients is demonstrated, allowing for interest from traditional investors and our continued funding. Our team operates the projects and new companies to bridge the gap between science and clinical experience. We source innovations that are too early for large corporate or venture investors. These inventions arise from clinicians all over the world who do not wish to become entrepreneurs Our ambition is to turn these …

95 similar entities Type: Incubators & VCs SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Building the next generation of medtech MedTech Engine is a powerful platform – a facilitator to unleash the potential of tomorrow's innovations. A catalyst for the next generation of medtech. Innovation isn’t a single eureka moment - it’s a journey of transformative thinking in strategy and practice from concept to launch. And we want to help medtechs approach every step of this journey with insight and fresh perspective. Medtech Engine will provide a set of services that we hope will help shake up the industry for the better. • Perspectives and case studies from those on the ground • Inspiring …

45 similar entities Type: Media Startup Activities: deeptech healthtech Technologies: A.I.

Precision treatment of immune disorders Polyneuron is a growing Basel-based biotechnology company active in the area of autoimmune disease treatments. The company was founded in 2014 as a spinout company from the University of Basel to develop novel treatments to combat immune disorders using its Antibody-CatchTM technology platform. The company currently employs about 10 people and has raised a significant amount in equity funding from top-tier VCs. We are a team of passionate and experienced scientists, entrepreneurs and investors willing to bring new therapies to patients.

129 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Creativ-Ceutical provides strategic pricing, market access and health economics consulting in life sciences. We provide both the strategic advice and the technical services to deliver results that meet your expectations. We have broad experience in the areas of central nervous system (CNS), oncology, vaccines, metabolic/cardiovascular diseases, and rare diseases. These are complex and developing fields, where treatment paradigms are in constant evolution and where clinical and economic issues require rigorous analysis to determine the best therapeutic choices. This experience allows us to address the most complex challenges and to anticipate pricing and market access issues that will arise in other …

72 similar entities Type: SMB Startup Activities: biotech deeptech Technologies: Synthetic Biology

Cultivate our positive impact Dômes Pharma is an independent, family-owned company that has been active in the pharmaceutical industry since 1947. It employs 400 people in France, England, Germany, Spain and the USA and has a consolidated turnover of 90 million euros. For over 70 years, the Group has been developing, manufacturing and marketing solutions for the health and well-being of pets. The Dômes Pharma Group has 3 complementary areas of expertise that integrate the entire value chain of medicine and cover all distribution channels. Animal Health

60 similar entities Type: SMB Activities: biotech healthtech deeptech Technologies: Synthetic Biology

Innovating to improve the lives of people living with chronic skin conditions LEO Innovation Lab is an independent unit, established by LEO Pharma as part of a long-term strategic decision to focus on patient needs. We nurture companies to lead the digital health revolution with the single goal of improving the quality of life for people living with chronic skin conditions. Located in Copenhagen, with hubs around the globe, the Innovation Lab creates companies and invests in ventures with disruptive potential in the healthcare arena. healthcare, psoriasis, ehealth, technology, skin conditions, patient-centric, artificial intelligence, health technology, machine learning, clinical trials, …

83 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: A.I. - Deep Learning A.I. A.I. - Machine Learning

Maintain vision and improve ocular health Nicox is an international ophthalmic R&D company, aiming to build a diversified portfolio of therapeutic products addressing the needs of eyecare practitioners and patients around the world. Our global growth strategy is focused on outstanding international collaborations and on our proprietary programs including those from our nitric oxide-donating research platform. For more information please visit www.nicox.com Pharmaceuticals, Ophthalmology, and Research and Development

81 similar entities Type: SMB Activities: healthtech manufacturing Technologies: Synthetic Biology

We represent the innovative pharmaceutical industry globally, with a focus on innovation, equitable access, and ethics. IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere. To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health. Biopharmaceuticals, …

Type: NGO, Think-tanks, Ed, & Culture Startup Activities: biotech deeptech Technologies: Synthetic Biology

NEW FRONTIERS IN NEUROSCIENCE Expertise, Experience, Innovation, Vision, Values. Neurentis PLC is a late-clinical stage UK biotech company, focusing on neuroscience and specialising in the development of novel treatments for mental health and other neurological and psychiatric diseases. Our product pipeline is balanced with 3 products: 1) an advanced lead drug candidate, a prescription pharmaceutical (selegiline), in a transdermal patch, for the treatment of Treatment-Resistant Depression (TRD) in the last stages of drug development, 2) a small molecule agonist of the oxytocin receptors for the treatment of Autism, Chronic and Neuropathic Pain and addiction to alcohol and opioids and 3) …

105 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Accelerating your medical technology development Team Consulting is a world-class partner in medical technology design and development. For nearly 40 years we have helped our clients create elegant, sustainable solutions to complex healthcare challenges. Our multidisciplinary team of experts bring a unique blend of human-centred design, engineering, science and regulatory expertise to your projects, working across drug delivery, MedTech, diagnostics, surgical and digital health. Extensive knowledge across the healthcare continuum We help you innovate at all stages of the healthcare continuum, from prevention technologies and diagnostics to innovative solutions for managing and treating conditions. Whether we're working with the world's …

101 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Making the difference... VTL has a long proven experience in introducing cutting-edge healthcare equipment and solutions from world-class manufacturers. Their diverse capabilities in Marketing, Sales, Application Support and Service of a wide and comprehensive range of medical equipment and consumables for healthcare facilities, rehabilitation and wellness, makes them a leading solution provider in the region. Established in 2007 with offices in Abu Dhabi, Dubai and Al Ain, Virtus Trading LLC (VTL), from its humble beginnings, today employ more than 30 professionals who have contributed to the 75 Million AED revenue in 2014. VTL offers customers advanced medical management services, medical …

78 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Accelerating treatments for millions of patients Arctic Therapeutics is a clinical-stage biopharmaceutical company on a mission to treat and even prevent some of the world’s most pressing diseases by utilizing genetic sequencing to analyze and map the genetic causes of diseases at a granular level, applying our findings to develop effective treatments. Our company was founded by Dr. Hakon Hakonarson in 2015 as a spin-off from the US-based Center for Applied Genomics (CAG), which he launched in 2006 and established it as the largest pediatric biobank and genomic database in the world. We maintain close research relationships with CAG and …

165 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Swiss Rockets: Innovating breakthrough medicines and transforming healthcare globally. The Swiss Rockets mission is to deliver outstanding results for patients, inventors, and investors. Founded in 2018 in Basel, Swiss Rockets is implementing a paradigm shift in healthcare. Cancer patients will benefit from new treatment therapies developed using innovative and disruptive methods. The Swiss Rockets team combines the necessary specialist knowledge and experience to efficiently and sustainably break new ground in cancer medicine. We aim to set new paradigms in healthcare. Disruptive innovation in everything we do will allow us to deliver breakthrough treatments to patients with cancer. We conduct our …

Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology

We believe in innovation, we seek value, we transform the present. Global project for health development and investment - Healthcare, Biotechnology, Digital Health, Medical Devices, MedTech, e-Health, Health Innovation, Ecosistemas de Innovación, Start Up Salud, Transferencia Tecnología, Agri-Food Tech, Spin Off, and Health Entrepreneurship

89 similar entities Type: SMB Activities: deeptech healthtech

In 2005, we were founded on a unified belief that neuromodulation could be used in novel ways to help patients break free from treatments they aren’t happy with. Because different modalities of neuromodulation had previously proven to be effective and safe, we recognized an opportunity to be the leader in this new frontier of medicine and took it head on. Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop safe and clinically backed treatments. Bringing new treatments to market …

Type: SMB Activities: healthtech biotech deeptech

We are a Swiss company on a mission to combat sepsis through magnetic blood purification. Member of @Wyss Zurich. We are a start-up medical device company originating from ETH Zurich and are passionate about developing life saving therapies. Our mission is to develop a breakthrough medical device for the most urgent healthcare issues. Focusing on patients’ needs, we translate the most promising research to the clinics and ensure patient access to scientific progress as soon as possible. As pioneers we take courageous decisions and are shaping the future of medicine. We first focus on finding an efficient therapy for patients …

80 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

We invent for life! In MSD -known as Merck & AMP; Co., Inc. in the United States and Canada, based in Rahway, New Jersey- We are united by our purpose of using science potential to save and improve lives in the world. For more than 130 years, we have contributed hope through the development of important medicines and vaccines. We aspire to be the leading biopharmaceutical research company of the world and, at present, we are at the forefront of research in innovative health solutions to advance the prevention and treatment of human and animal diseases. We encourage a diverse …

70 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Expertise that matters Mercodia utilizes its 30+ years of experience as a world-leading manufacturer of cardiometabolic immunoassays to provide tailored bioanalysis solutions for pharma and biotech companies. We specialize in assay development and validation, PK/PD, immunogenicity testing, and biomarker testing, mainly focusing on large molecules, peptides, and oligonucleotide therapeutics in preclinical and clinical development. We are GLP-certified and work in accordance with ICH GCP, EMA, and FDA guidelines. Our team of expert scientists quickly provides reproducible, reliable, and high-quality data that meets regulatory requirements. We prioritize speed and flexibility while delivering cost-effective solutions. Our vision is to improve human health …

140 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Accessible innovation designed to improve patient outcomes Yorkshire based Med Tech company specialising in Orthopaedics. A small company planning on making a big impact ! Orthopaedics, Medical Devices, and Innovation

190 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Helping health & biotech companies, researchers and entrepreneurs making their projects and dreams come true. GENESIS Biomed is a consultancy firm in the biomedical healthcare sector specialized in providing consulting services in the genesis and first phases of lifecycle of biomedical spin-off and start-up companies, entrepreneurs and research centers. Based in our expertise we help entrepreneurs and researchers to shape their business plan and we support them in the private fundraising process. We have raised 68,5 M€ in the last years in 20 rounds. We are Associate Partner at EIT Health and we are engaged to 23 EU projects with …

52 similar entities Type: SMB Activities: deeptech healthtech consulting entrepreneurship fintech biotech Technologies: A.I.

Healthcare Specialist Alea S.r.l. It is an Italian company, based in Moncalieri (TO) born thanks to the thirty -year experience in the medical and health sector of the founding members. Multiple sectors of competence: infusional systems, consumable for hospital wards, laboratory diagnostic devices and electromedical equipment. Alea S.r.l. It is based on a remarkable knowledge of the European medical market and, with its specialized technicians, studies and develops innovative products and projects that are made to produce by primary foreign companies (including Tuoren, Medcaptain and Citest), with which it entertains a fruitful collaboration and marketing in different European states.

31 similar entities Type: SMB Activities: healthtech deeptech

Working to build a health system that is effective, efficient, & driven by a clear vision: patient needs above all else. The Milken Institute's FasterCures believes that transformative and life-saving science should be fully realized and deliver better treatments to the people who need them. biomedical research, R&D collaboration, science policy, venture philanthropy, Partnering for Cures, science communications, medical research, and Health Citizenship

61 similar entities Type: SMB Activities: biotech deeptech

Translating science into global health impact. Translating scientific discoveries into affordable, globally accessible public health solutions. IAVI is a non-profit that develops vaccines and antibodies for HIV, tuberculosis, and emerging infectious diseases. AIDS vaccine, research and development, product development partnership, HIV/AIDS, vaccine development, global health, capacity strengthening, clinical trials, and scientific research

59 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Because Patients Can't Wait® As the largest life sciences association in New Jersey, BioNJ is a powerful network of over 400 Member companies representing research-based life sciences companies and stakeholders. Because Patients Can’t Wait®, we are dedicated to propelling the rich innovation ecosystem in the New Jersey region to stimulate and support innovation, improve and save lives, and lower the hurdles of healthcare advancements for society. As the industry’s voice in New Jersey, we fulfill our mission by ensuring that: Science is Supported Companies are Created Drugs are Developed Patients are Paramount Biotechnology, Pharmaceuticals, Life Sciences, New Jersey, Networking, Advocacy, …

74 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Celltrion is a leading biopharmaceutical company that specializes in research, development and manufacturing of innovative therapeutics. We are committed to delivering innovative and affordable medications to promote patients’ access to advanced therapies. We have been at the forefront of biotherapeutic development uncovering new ways of targeting the drivers of disease by creating next-generation biologics and small molecule products. For additional information on our guidelines, please visit: http://tinyurl.com/bdh9bxs9 To transform possibility into a reality by promoting the health and welfare of mankind. We thrive to meet the needs of people who previously had limited access to advanced therapeutics.

118 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Where Empathy Meets Science to Accelerate Life Sciences Research Alira Health is a global healthcare firm whose mission is to humanize healthcare and life sciences in partnership with patients. We provide consulting and clinical services enabled by technology and real-world evidence. From development to medical care, we complement the expertise of our pharma, biotech, and medtech clients with a full spectrum of services across their entire solutions lifecycle. Nuclear medicine, Rare disease, Lupus, Myasthenia gravis, Robotics, MDR, CDMO medtech, Cell & gene, Value-based contracting, Drug delivery systems, Antibody–drug conjugates, Biosimilars, CDMO medtech, and CDMO biologics

232 similar entities Type: SMB Activities: biotech consulting deeptech healthtech Technologies: Data Analytics

Dedicated to driving more treatments to more patients more quickly by testing approved therapies for new indications Cures Within Reach leverages the speed, safety and cost-effectiveness of testing already approved therapies for new indications to improve patient quality and length of life, serving philanthropic and/or commercial uses – driving more treatments to more patients more quickly. Read about our ongoing trials at https://www.cureswithinreach.org/programs/current-repurposing-research-projects/. medical research, pharmaceutical, social entrepreneur, and philanthropy

25 similar entities Type: SMB Activities: biotech deeptech

We contribute knowledge and innovation to achieve excellence in all our projects. Euromedice is a multichannel medical editorial born more than 20 years ago. We are specialized in the creation and development of scientific content projects edited in any type of support; printed, web, app, face -to -face ... We are a company formed by a work team of 28 people, mostly higher graduates and with a turnover of approximately 10 million euros. Our clients are pharmaceutical companies, scientific societies and public administrations fundamentally. Our plant is in Spain, with offices in Madrid and Barcelona. Our vocation is to create …

17 similar entities Type: SMB Activities: biotech deeptech

Let's bring medicines to the world, because the world is waiting NDA Group is the regulatory powerhouse of SSI Strategy. For more than 25 years we’ve leveraged our extensive experience and global network to help you optimize your regulatory strategies, expedite filings, and secure successful approvals in key markets worldwide. By integrating our regulatory proficiency with SSI Strategy's strategic capabilities in clinical development, medical affairs and commercial planning, we provide biotech companies with a holistic solution that maximizes the value of their assets and ensures timely access to innovative therapies. We understand that bringing a new therapy to market is …

123 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Developing first-in-class solutions for unmet health and personal care needs Results through innovation. We are an innovative biotechnology group with two divisions. Our consumer health arm has commercial products for the personal care market addressing nail, skin, scalp and hair issues. NovaBiotics pharma division has advanced clinical-stage product candidates for medically unmet, life-limiting inflammatory, infectious and respiratory disease. Our highly disruptive solutions to personal care and health needs address significant global markets. biotechnology, biologics, infectious disease, and drug discovery & development

155 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Together for a healthier world Welcome to the Medice Health Family Based on our long -term tradition as a family business, we will noticeably help shape the future of medicine in the coming decade. We will be a leading global developer and provider of innovative, integrated and diverse health solutions. We are the Health Family for our patients, doctors, pharmacists, employees and partners. Nephrology, ADHD, urology, self -medication, prescription medicines, and digital health solutions

212 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Driven by innovation to contribute to a healthier and happier life We share a deep commitment to service and customer service, which, combined with our professionalism, helps us achieve our primary objective: giving a longer, healthier, happier life to society by offering safe and efficacious drugs. We are able to achieve this goal through research and analysis, as well as an understanding of the needs of our patients, professionals, distributors and institutional representatives. Medicamentos de prescripción, Nutraceuticos, and Productos farmacéuticos

153 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Providing innovative services to the healthcare industry, professional societies and patient groups. Oxford PharmaGenesis is a HealthScience communications consultancy. We are the largest independently owned and financed company in the medical communications sector. Founded in 1998, our award-winning organization now comprises more than 500 talented people working from offices and homes worldwide. We are connected by a strong company culture and a clear mission: to accelerate adoption of evidence-based innovations for patients in areas of unmet medical need. Contact us to find out how we apply powerful thinking, dedicated to your success. Medical affairs, Commercial and Marketing, Value demonstration, Real-world …

104 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Data Analytics

A leading nationwide clinical research site network pursing life-changing therapies committed to better patient outcomes CenExel is a leading integrated, wholly owned, nationwide clinical research site network comprised of 18 Centers of Excellence in major metropolitan areas across the U. S. With 40+ years of experience, our Centers of Excellence deliver deep scientific expertise, premium data, operational efficiencies, and exceptional patient engagement to drive successful complex clinical trial outcomes. The world's most results-driven Pharma, Biotech, and Clinical Research Organizations trust our strategic approach and benefit from our collaboration and unified sites’ commitment to real world solutions. Rely on us to …

84 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Delivering Excellence in Life Sciences Our purpose at Jenburkt Pharmaceuticals Ltd is to serve those in need of quality healthcare by bringing revolutionary, life-changing therapeutic solutions that are accessible to all. We believe in serving our patients – through them, we serve God, humanity and nation. Way back in the twentieth century, a visionary in the field of healthcare and philanthropic work – Shri Nandlal Mulji Bhuta laid the foundation for several companies. Today, with over 850+ committed team members across functions pan-India,we have 11 million+ prescriptions generated annually from 400,000+ pharmacies across the globe. Our organisation caters to large …

125 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

The Cell Therapy Venture Builder MedXCell is a European cell therapy venture builder with a strong industrial mindset and a global perspective. Our focus is on technologies, techniques or novel applications in major diseases such as cancer, autoimmune, neurological and degenerative disorders. Established in 2018, we have offices in Switzerland, the EU (France) and the US (Cambridge, MA) and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development and funding capabilities. Biotechnology, Cell Therapy, Immunotherapy, NK Cells, Mesenchymal Stromal Cells, Immuno-oncology, and Osteoarthritis

410 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We Chase the Miracles of Science to Improve People’s Lives. Sanofi is an innovative, global biofarmaceutical company, which is guided by one goal, so that according to the slogan "We Chase the Miracles of Science to Improve People’s Lives", focusing on the power of science, change the world for the better. In 100 countries, the teams involved and talented work to change the face of medicine, making impossible possible. The company creates therapies and vaccines that save lives to millions of people around the world. We have a wide range of specialized medicinal products and services in many therapeutic areas …

3 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Changing lives with next generation peptide therapeutics Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on …

36 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We Embrace the Challenge in Science Dompé farmaceutici is an international biopharmaceutical company involved in all activities of the pharmaceutical value chain, from research to development, production and marketing. As a long-established family company, we blend the stability that comes from our 130-year heritage with the agility and dynamism of a start-up. We can turn transformative breakthroughs into treatments because we have the right qualities and capabilities to deliver new drugs. Our 160,000 square meter R&D and production site in L’Aquila, Italy, is the heart of Dompé. Here, we conduct vital research, and produce and distribute our primary care and …

84 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology